| Literature DB >> 29712770 |
Iliana Angelidou1, Akrivi Chrysanthopoulou1, Alexandros Mitsios1, Stella Arelaki2, Athanasios Arampatzioglou1, Konstantinos Kambas1, Dimitrios Ritis1, Victoria Tsironidou1, Ioannis Moschos3,4, Vasiliki Dalla3, Dimitrios Stakos1, Georgios Kouklakis3,4, Ioannis Mitroulis5, Konstantinos Ritis6,3, Panagiotis Skendros6,3.
1. Laboratory of Molecular Hematology, Democritus University of Thrace, Alexandroupolis 68100, Greece.
2. Department of Pathology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis 68100, Greece.
3. First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis 68100, Greece.
4. Gastrointestinal Endoscopy Unit, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis 68100, Greece; and.
5. Department of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technical University of Dresden, 01307 Dresden, Germany.
6. Laboratory of Molecular Hematology, Democritus University of Thrace, Alexandroupolis 68100, Greece; kritis@med.duth.gr pskendro@med.duth.gr.
Abstract
Entities:
Mesh:
Adult
Autophagy/drug effects
Autophagy/physiology
Colitis, Ulcerative/drug therapy
Colitis, Ulcerative/metabolism
Colon/drug effects
Colon/metabolism
Crohn Disease/drug therapy
Crohn Disease/metabolism
Extracellular Traps/drug effects
Extracellular Traps/metabolism
Female
Humans
Inflammation/drug therapy
Inflammation/metabolism
Interleukin-1beta/metabolism
Intestinal Mucosa/drug effects
Intestinal Mucosa/metabolism
Male
Mesalamine/pharmacology
Middle Aged
Neutrophil Activation/drug effects
Neutrophil Activation/physiology
Neutrophils/drug effects
Neutrophils/metabolism
Transcription Factors/metabolism
Substances:
DDIT4 protein, human
Interleukin-1beta
Transcription Factors
Mesalamine
Year: 2018 PMID: 29712770 DOI: 10.4049/jimmunol.1701643
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422